Pixium Vision S.A.
PAR: ALPIX.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Lloyd Diamond
- Employees
- 40
- Headquarters
- Paris, France
- IPO year
- 2014
- Market cap
- €1.2M
- Website
- https://www.pixium-vision.com
Loading ALPIX…
Loading profile data…Frequently asked questions about ALPIX
What does Pixium Vision S.A. (ALPIX.PA) do?
Pixium Vision SA, a bioelectronics and brain machine interface technology company, specialized in neuromodulation application. It develops PRIMA System, a bionic vision system for patients with severe vision loss due to retinal degeneration caused by the dry atrophic form of Age-related Macular Degeneration (AMD); and to treat bilndness, which r...
Where does ALPIX.PA trade?
Pixium Vision S.A. (ALPIX.PA) trades on the Euronext Paris.
What sector is ALPIX.PA in?
Pixium Vision S.A. (ALPIX.PA) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Pixium Vision S.A.?
Lloyd Diamond is the chief executive officer of Pixium Vision S.A. (ALPIX.PA).
Where is Pixium Vision S.A. headquartered?
Pixium Vision S.A. is headquartered in France.
Does ALPIX.PA pay a dividend?
Pixium Vision S.A. (ALPIX.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALPIX.PA go public?
Pixium Vision S.A. (ALPIX.PA) completed its initial public offering in 2014.